Fortrea (FTRE)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$20.46-1.78%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · FTRE
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 2,666.7 | 2,723.4 | 2,696.4 | 2,842.5 | 2,837.0 | 3,057.5 | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 409.4 | 456.4 | 560.7 | 448.1 | 416.1 | 303.1 | — |
| Operating Income | 12.8 | (872.6) | (161.9) | 32.0 | 187.1 | 114.3 | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | 69.8 | 0.2 | 0.2 | — |
| EBT, Incl. Unusual Items | (52.7) | (983.0) | (275.0) | (30.5) | 187.0 | 136.4 | — |
| Income Tax Expense | 16.0 | 3.2 | (3.5) | 1.2 | 41.1 | 38.4 | — |
| Net Income | |||||||
| Net Income | (71.5) | (986.2) | (328.5) | (25.0) | 186.2 | 98.0 | — |
| Per Share | |||||||
| Basic EPS | (0.75) | (10.81) | (3.67) | (0.29) | 2.09 | 1.10 | — |
| Diluted EPS | (0.71) | (10.81) | (3.67) | (0.29) | 2.09 | 1.10 | — |
| Revenue per Share | 26.35 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 95.6 | — | 89.5 | 88.8 | 88.8 | 88.8 | — |
| Diluted Weighted Avg Shares | 101.2 | — | 89.5 | 88.8 | 88.8 | 88.8 | — |
| Supplemental | |||||||
| EBITDA | — | (794.6) | (76.6) | 121.3 | 272.6 | 280.6 | — |
| EBIT | 12.8 | (872.6) | (161.9) | 32.0 | 187.1 | 114.3 | — |
| Effective Tax Rate | -30.4% | — | — | -3.9% | 22.0% | 28.2% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.